Quem fabrica Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Reckitt Benckiser (Healthcare) SA-NV (BE)

A qual classe ATC pertence Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: ATC A02BX13 Alginic Acid. ATC é a classificação anatômica, terapêutica e química da OMS.

OTC

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: Chewable tablet (Oral use)

Chewable tablet

INN: Sodium Alginate

Atualizado: 2026-04-11

Disponível em:

🇩🇪🇬🇧🇷🇴🇷🇺🇹🇷

Forma

Chewable tablet

Posologia

—

Via de administração

Oral use

Armazenamento

—

Sobre este produto

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.